Reduced Risk of Colorectal Cancer With Use of Oral Bisphosphonates: A Systematic Review and Meta-Analysis

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis

(2013) Nelson Watts et al.   Endocrine Practice

The Intermediate Enzymes of Isoprenoid Metabolism as Anticancer Targets

(2012) Andrew Wiemer et al.   Anti-Cancer Agents in Medicinal Chemistry

A Prospective Study of Bisphosphonate Use and Risk of Colorectal Cancer

(2012) Hamed Khalili et al.   JOURNAL OF CLINICAL ONCOLOGY

Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate—Danish National Register Based Cohort Study

(2012) M. Pazianas et al.   OSTEOPOROSIS INTERNATIONAL

Occurrence of Gastrointestinal Cancer in Users of Bisphosphonates and Other Antiresorptive Drugs Against Osteoporosis

(2011) Peter Vestergaard   CALCIFIED TISSUE INTERNATIONAL

Exposure to bisphosphonates and risk of colorectal cancer

(2011) Harminder Singh et al.   CANCER

Use of Bisphosphonates and Reduced Risk of Colorectal Cancer

(2011) Gad Rennert et al.   JOURNAL OF CLINICAL ONCOLOGY

Bisphosphonates and esophageal cancer—a pathway through the confusion

(2011) William G. Dixon et al.   Nature Reviews Rheumatology

Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk

(2010) P A Newcomb et al.   BRITISH JOURNAL OF CANCER

Bisphosphonates as Anticancer Therapy for Early Breast Cancer

(2010) Reshma Mahtani et al.   Clinical Breast Cancer

Can we Consider Zoledronic Acid a New Antitumor Agent? Recent Evidence in Clinical Setting

(2010) D. Santini et al.   CURRENT CANCER DRUG TARGETS

Exposure to Oral Bisphosphonates and Risk of Esophageal Cancer

(2010) Chris R. Cardwell et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Long-Term Use of Bisphosphonates in Osteoporosis

(2010) Nelson B. Watts et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Unusual mid-shaft fractures during long-term bisphosphonate therapy

(2009) Clarita V. Odvina et al.   CLINICAL ENDOCRINOLOGY

Efficient Killing of Human Colon Cancer Stem Cells by    T Lymphocytes

(2009) M. Todaro et al.   JOURNAL OF IMMUNOLOGY

Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK

(2009) J. Compston et al.   MATURITAS

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

(2009) Michael Gnant et al.   NEW ENGLAND JOURNAL OF MEDICINE

The bisphosphonate zoledronic acid inhibits the growth of HCT-116 colon carcinoma cells and induces tumor cell apoptosis

(2008) Lilian Sewing et al.   APOPTOSIS